世界のアレルギー免疫療法市場2020-2024

◆英語タイトル:Global Allergy Immunotherapies Market 2020-2024
◆商品コード:IRTNTR41320
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年3月24日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア太平洋、ヨーロッパ、中東アフリカ、北米、南米
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはアレルギー免疫療法の世界市場について調査・分析し、エグゼクティブサマリー、市場環境、市場規模、ファイブフォース分析、製品別(SCIT、SLIT)分析、顧客状況、地域別状況、市場の要因と課題、企業状況、企業分析などを含め、次の構成でお届けいたします。
・エグゼクティブサマリ
・市場環境
・市場規模
・ファイブフォース分析
・アレルギー免疫療法の世界市場:製品別(SCIT、SLIT)
・顧客状況
・地域別状況
・市場の要因・課題
・企業状況
・企業分析
【レポートの概要】

Global Allergy Immunotherapies Market 2020-2024
Technavio has been monitoring the global allergy immunotherapies market and it is poised to grow by USD 626.77 mn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on global allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies. In addition, growing popularity of slit is anticipated to boost the growth of the global allergy immunotherapies market as well.

Market Segmentation
Technavio’s global allergy immunotherapies market is segmented as below:
Product:
• SCIT
• SLIT

Geographic Segmentation:
• APAC
• Europe
• MEA
• North America
• South America

Key Trends for global allergy immunotherapies market growth
This study identifies growing popularity of slit as the prime reasons driving the global allergy immunotherapies market growth during the next few years.

Prominent vendors in global allergy immunotherapies market
We provide a detailed analysis of around 25 vendors operating in the global allergy immunotherapies market 2020-2024, including some of the vendors such as Aimmune Therapeutics Inc., ALK-Abelló AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA and Stallergenes Greer Plc .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/allergy-immunotherapies-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

•Executive Summary
o Market Overview
•Market Landscape
o Market ecosystem
o Value chain analysis
•Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
•Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
•Market Segmentation by Product
o Market segments
o Comparison by Product placement
o SCIT – Market size and forecast 2019-2024
o SLIT – Market size and forecast 2019-2024
o Market opportunity by Product
•Customer landscape
o Overview
•Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Europe – Market size and forecast 2019-2024
o North America – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
•Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher-priced units
o Market challenges
o Market trends
•Vendor Landscape
o Overview
o Landscape disruption
•Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Aimmune Therapeutics Inc.
o ALK-Abelló AS
o Allergy Therapeutics Plc
o ASIT Biotech SA
o DBV Technologies SA
o HAL Allergy BV
o Jubilant Life Sciences Ltd.
o Laboratorios LETI SLU
o Merck KGaA
o Stallergenes Greer Plc
•Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
•1.Key Finding 1
•2.Key Finding 2
•3.Key Finding 3
•4.Key Finding 5
•5.Key Finding 6
•6.Key Finding 7
•7.Key Finding 8
•8.Market in focus
•9.Parent market
•10.Market characteristics
•11.Product / Service portfolio of key vendors included in the market definition
•12.Market segments
•13.Global – Market size and forecast 2019 – 2024 ($ million)
•14.Global market: Year-over-year growth 2019 – 2024 (%)
•15.Five forces analysis 2019 & 2024
•16.Bargaining power of buyers
•17.Bargaining power of suppliers
•18.Threat of new entrants
•19.Threat of substitutes
•20.Threat of rivalry
•21.Market condition – Five forces 2019
•22.Product placement – Market share 2019-2024 (%)
•23.Comparison by Product placement
•24.SCIT – Market size and forecast 2019-2024 ($ million)
•25.SCIT – Year-over-year growth 2019-2024 (%)
•26.SLIT – Market size and forecast 2019-2024 ($ million)
•27.SLIT – Year-over-year growth 2019-2024 (%)
•28. Market opportunity by Product
•29.Customer landscape
•30.Market share by geography 2019-2024 (%)
•31.Geographic comparison
•32.Europe – Market size and forecast 2019-2024 ($ million)
•33.Europe – Year-over-year growth 2019-2024 (%)
•34.North America – Market size and forecast 2019-2024 ($ million)
•35.North America – Year-over-year growth 2019-2024 (%)
•36.APAC – Market size and forecast 2019-2024 ($ million)
•37.APAC – Year-over-year growth 2019-2024 (%)
•38.MEA – Market size and forecast 2019-2024 ($ million)
•39.MEA – Year-over-year growth 2019-2024 (%)
•40.South America – Market size and forecast 2019-2024 ($ million)
•41.South America – Year-over-year growth 2019-2024 (%)
•42.Key leading countries
•43.Market opportunity by geography ($ million)
•44.Impact of drivers and challenges
•45.Vendor landscape
•46.Landscape disruption
•47.Industry risks
•48.Vendors covered
•49.Market positioning of vendors
•50.Aimmune Therapeutics Inc. – Overview
•51.Aimmune Therapeutics Inc. – Business segments
•52.Aimmune Therapeutics Inc. – Key offerings
•53.Aimmune Therapeutics Inc. – Key customers
•54.Aimmune Therapeutics Inc. – Segment focus
•55.ALK-Abelló AS – Overview
•56.ALK-Abelló AS – Product and service
•57.ALK-Abelló AS – Key offerings
•58.ALK-Abelló AS – Key customers
•59.ALK-Abelló AS – Segment focus
•60.Allergy Therapeutics Plc – Overview
•61.Allergy Therapeutics Plc – Business segments
•62.Allergy Therapeutics Plc – Key offerings
•63.Allergy Therapeutics Plc – Key customers
•64.Allergy Therapeutics Plc – Segment focus
•65.ASIT Biotech SA – Overview
•66.ASIT Biotech SA – Business segments
•67.ASIT Biotech SA – Key offerings
•68.ASIT Biotech SA – Key customers
•69.ASIT Biotech SA – Segment focus
•70.DBV Technologies SA – Overview
•71.DBV Technologies SA – Business segments
•72.DBV Technologies SA – Key offerings
•73.DBV Technologies SA – Key customers
•74.DBV Technologies SA – Segment focus
•75.HAL Allergy BV – Overview
•76.HAL Allergy BV – Business segments
•77.HAL Allergy BV – Key offerings
•78.HAL Allergy BV – Key customers
•79.HAL Allergy BV – Segment focus
•80.Jubilant Life Sciences Ltd. – Overview
•81.Jubilant Life Sciences Ltd. – Business segments
•82.Jubilant Life Sciences Ltd. – Key offerings
•83.Jubilant Life Sciences Ltd. – Key customers
•84.Jubilant Life Sciences Ltd. – Segment focus
•85.Laboratorios LETI SLU – Overview
•86.Laboratorios LETI SLU – Business segments
•87.Laboratorios LETI SLU – Key offerings
•88.Laboratorios LETI SLU – Key customers
•89.Laboratorios LETI SLU – Segment focus
•90.Merck KGaA – Overview
•91.Merck KGaA – Business segments
•92.Merck KGaA – Key offerings
•93.Merck KGaA – Key customers
•94.Merck KGaA – Segment focus
•95.Stallergenes Greer Plc – Overview
•96.Stallergenes Greer Plc – Product and service
•97.Stallergenes Greer Plc – Key offerings
•98.Stallergenes Greer Plc – Key customers
•99.Stallergenes Greer Plc – Segment focus
•100.Currency conversion rates for US$
•101.Research Methodology
•102.Validation techniques employed for market sizing
•103.Information sources
•104.List of abbreviations



【掲載企業】

Aimmune Therapeutics Inc., ALK-Abelló AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA, Stallergenes Greer Plc

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のアレルギー免疫療法市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆